Thomas Tan

Founder & CEO at Romulus Therapeutics

Presenter

Seng-Lai (Thomas) Tan is a biotechnology executive and drug discovery leader with over 25 years of experience spanning small- and large-molecule therapeutics, including kinase inhibitors and multi-specific antibodies. He has held leadership roles at Eli Lilly, Amgen, Roche, and EMD Serono, and served as Chief Scientific Officer at Bicara Therapeutics, Immunitas Therapeutics, and TFC Therapeutics, advancing multiple oncology and immunology programs toward clinical development.